Insider Transactions in Q3 2021 at Bio Atla, Inc. (BCAB)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Guy Levy Director |
BUY
Grant, award, or other acquisition
|
Indirect |
267,900
+19.36%
|
$7,501,200
$28.0 P/Share
|
|
Sep 15
2021
|
Lawrence Steinman |
SELL
Open market or private sale
|
Direct |
450
-2.32%
|
$16,200
$36.82 P/Share
|
|
Aug 26
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,883
-6.84%
|
$268,437
$39.59 P/Share
|
|
Aug 26
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
33,244
-4.38%
|
$1,329,760
$40.26 P/Share
|
|
Aug 24
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
4,533
-0.57%
|
$185,853
$41.6 P/Share
|
|
Aug 24
2021
|
Jay M Phd Short Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,747
+0.96%
|
$139,446
$18.0 P/Share
|
|
Aug 24
2021
|
Guy Levy Director |
SELL
Open market or private sale
|
Indirect |
546,709
-19.67%
|
$21,321,651
$39.65 P/Share
|
|
Aug 16
2021
|
Lawrence Steinman |
SELL
Open market or private sale
|
Direct |
450
-2.27%
|
$18,000
$40.6 P/Share
|
|
Jul 15
2021
|
Lawrence Steinman |
SELL
Open market or private sale
|
Direct |
450
-2.22%
|
$17,100
$38.29 P/Share
|
|
Jul 07
2021
|
Jay M Phd Short Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
5,378
+0.41%
|
-
|